Menu
Currency
GWAS Study

Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease.

Turpin W, Espin-Garcia O, Bedrani L et al.

31251335 PubMed ID
GWAS Study Type
1075 Participants
45 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

TW
Turpin W
EO
Espin-Garcia O
BL
Bedrani L
MK
Madsen K
MJ
Meddings JB
RG
Raygoza Garay JA
SM
Silverberg MS
SM
Smith MI
GA
Griffiths AM
MP
Moayyedi P
MJ
Marshall JK
MD
Mack D
SE
Seidman EG
RM
Ropeleski M
FB
Feagan BG
JK
Jacobson K
TD
Turner D
WT
Walters T
PA
Paterson AD
XW
Xu W
CK
Croitoru K
Chapter II

Abstract

Summary of the research findings

Excessive intestinal permeability or intestinal barrier dysfunction as measured by various assays has been observed in various diseases. However, little is known about the factors contributing to altered gut permeability in these diseases. Our objective was to determine the genetic determinants of altered gut permeability as measured by the lactulose mannitol fractional excretion ratio (LacMan ratio) in 1075 healthy first-degree relatives of patients with Crohn's disease (CD). In a targeted analysis of single nucleotide polymorphisms (SNPs) located in genes associated with intestinal barrier function related or not to inflammatory bowel disease, we did not find a significant association with intestinal permeability. In an untargeted genome-wide association analysis, the top 100 associations were located in 22 genomic loci, although they were not statistically significant after correction for multiple testing (raw P values [1.8 × 10-7 - 1.4 × 10-5]. The lowest P value was obtained for rs9616637 (22q13.33, C22orf34), for which the minor allele A was associated with a decreased LacMan ratio. These results suggest that host genetic background has limited contribution toward intestinal permeability. Despite this, our study is currently the largest of its kind assessing gut permeability in vivo. It remains possible that smaller genetic effect sizes on LacMan ratio are not detectable in this sized cohort. Larger studies are warranted to identify the potential genetic contribution to intestinal permeability.

1,075 European ancestry first-degree relatives of Crohn’s disease patients

Chapter III

Study Statistics

Key metrics and study information

1075
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Canada, U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.